| Followers | 79 |
| Posts | 12252 |
| Boards Moderated | 3 |
| Alias Born | 06/03/2008 |
Friday, February 13, 2026 9:30:09 AM
I look at various other social media on RGBP, but like to post here as I know some of them watch this board. There is one "leader" that is in total denial, and is criticizing others for selling, even though 98% of the dividend shares haven't been sold yet, to wait for a better price, along with others. They don't understand simple math of dilution, as so think a stock down 90% in 3 days is "cheap" and can't go lower. In other words, typical OTC investors.
Quarterly financials are out and maybe even a bigger disaster than typical. He's really getting old, and I am wondering if this is the last big bang for him to cash out and then leave or just go into silence.
Quarterly financials are out and maybe even a bigger disaster than typical. He's really getting old, and I am wondering if this is the last big bang for him to cash out and then leave or just go into silence.
Recent RGBPP News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 07:49:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 11:13:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 08:49:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 11:01:54 AM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 01/13/2026 05:15:05 AM
- Form 1-A POS - • Edgar (US Regulatory) • 01/08/2026 06:00:40 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/30/2025 03:38:37 PM
- Form 253G1 - • Edgar (US Regulatory) • 12/05/2025 08:57:53 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 11/17/2025 12:21:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 04:57:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 10:06:02 AM
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2025 05:12:32 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 08/29/2025 08:00:45 PM
- Form 1-A-W - Withdrawal of offering statement [Regulation A] • Edgar (US Regulatory) • 08/12/2025 08:52:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2025 10:18:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 07:19:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 07:23:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 03:15:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/13/2025 08:30:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 08:29:36 PM
